Loss and gain of aminoglycoside resistance in global clone 2Acinetobacter baumanniiin Australia via modification of genomic resistance islands and acquisition of plasmids
Authors:
- 30 May 2016
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 71 (9) , 2432-2440
Abstract
The objective of this study was to examine the evolution of carbapenem-resistant global clone 2 (GC2) Acinetobacter baumannii in Australia focusing on the complement of aminoglycoside resistance genes and their location in resistance islands and plasmids. Sixty-two carbapenem-resistant GC2 A. baumannii isolates with various aminoglycoside resistance profiles and resistance gene content that were recovered over the period 1999–2010 from hospitals on the east coast of Australia were examined. PCR was used to link relevant contigs retrieved from whole genomes sequenced using Illumina HiSeq and assembled de novo using Velvet. Resistance phenotypes were extended to include additional antibiotics using a disc diffusion assay. Sixty-one isolates were ST208 (formerly ST92; Oxford scheme) and one was ST425. All isolates included the oxa23 carbapenem resistance gene in Tn2006 located in the same position in AbGRI1-2, along with the ISAba1-sul2-CR2Δ-tetA(B)-tetA(R)-CR2-strB-strA configuration. All isolates harboured either AbGRI2-1 carrying the aacC1 (gentamicin resistance) cassette or a variant derived from it via loss of some of the island content. When aacC1 was lost, aminoglycoside resistance was sometimes regained via acquisition of aadB (gentamicin, kanamycin and tobramycin resistance) in pRAY*-v1 or TnaphA6 (amikacin, kanamycin and neomycin resistance) in a repAci6 plasmid. A small cryptic plasmid or a deletion variant of this plasmid was always present and a large cryptic plasmid was also variably present. The extensively antibiotic-resistant GC2 isolates from Sydney, Brisbane and Canberra appear to have arisen from a single import that was introduced into Australia in, or prior to, 1999 that then evolved and spread.Keywords
Funding Information
- NHMRC (1026189, 1043830)
- NHMRC (1043830)
This publication has 39 references indexed in Scilit:
- ISAba1 targets a specific position upstream of the intrinsic ampC gene of Acinetobacter baumannii leading to cephalosporin resistanceJournal of Antimicrobial Chemotherapy, 2013
- Global evolution of multidrug-resistant Acinetobacter baumannii clonal lineagesInternational Journal of Antimicrobial Agents, 2013
- Variants of the gentamicin and tobramycin resistance plasmid pRAY are widely distributed in AcinetobacterJournal of Antimicrobial Chemotherapy, 2012
- Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistanceClinical Microbiology and Infection, 2012
- Aminoglycoside resistance in multiply antibiotic-resistant Acinetobacter baumannii belonging to global clone 2 from Australian hospitalsJournal of Antimicrobial Chemotherapy, 2011
- The Population Structure of Acinetobacter baumannii: Expanding Multiresistant Clones from an Ancestral Susceptible Genetic PoolPLOS ONE, 2010
- AbaR5, a Large Multiple-Antibiotic Resistance Region Found in Acinetobacter baumanniiAntimicrobial Agents and Chemotherapy, 2009
- Worldwide Dissemination of theblaOXA-23Carbapenemase Gene ofAcinetobacter baumannii1Emerging Infectious Diseases, 2009
- Antibiotic resistance determinants in nosocomial strains of multidrug-resistant Acinetobacter baumanniiJournal of Antimicrobial Chemotherapy, 2008
- Genetic Environment and Transcription of ampC in an Acinetobacter baumannii Clinical IsolateAntimicrobial Agents and Chemotherapy, 2004